Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Water-soluble prodrug of tamibarotene, and preparation method and applications thereof

A Tamibarotene, water-soluble technology, applied in the field of organic compound synthesis and pharmaceutical applications, can solve the problems of poor water solubility, inability to delay drug release, etc., and achieve the effect of good water solubility

Inactive Publication Date: 2010-03-10
SHANDONG UNIV
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

N, N-dimethylethanolamine salt derivatives have good water solubility but cannot delay the release of drugs, N, N-dimethylethanolamine ester derivatives are expected to delay the release of drugs but their water solubility is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Water-soluble prodrug of tamibarotene, and preparation method and applications thereof
  • Water-soluble prodrug of tamibarotene, and preparation method and applications thereof
  • Water-soluble prodrug of tamibarotene, and preparation method and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Embodiment 1: Tamibarotene N, the preparation of N-dimethylethanolamine (DMEA) ester (carbodiimide method)

[0068] Tamibarotene (3.51g, 10mmol) was dissolved in 50ml of tetrahydrofuran, then DCC (3.09g, 15mmol) and HOBt (2.03g, 15mmol) were added, and the reaction was stirred at 0°C for 12 hours to generate Tamibar 1-Hydroxybenzotriazole active ester of rotin. Then DMEA (4.46g, 50mmol) was added, and the reaction was stirred at 0°C for 24h. The reaction solution was evaporated under reduced pressure to remove the solvent tetrahydrofuran (THF). After the residue was dissolved in a small amount of ethyl acetate, silica gel column chromatography was performed. The ester was used as the eluent for elution, and the eluent was rotary evaporated under reduced pressure to remove the solvent, and the DMEA ester of tamibarotene was prepared (white powder, yield 46.3%). mp 138.0-139.0°C. ESI-MS (m / z): 423.5 (M+H). 1 HNMR (DMSO-d 6 )δ: 1.238~1.251(m, 12H, 4×CH 3 ); 1.647(s, 4...

Embodiment 2

[0069] Embodiment 2: Tamibarotene N, the preparation of N-dimethylethanolamine (DMEA) ester (CDI method)

[0070] Tamibarotene (3.51 g, 10 mmol) was dissolved in 50 ml of tetrahydrofuran, then CDI (4.86 g, 30 mmol) was added, and the reaction was stirred at room temperature for 24 hours. Then DMEA (4.46g, 50mmol) was added, and the reaction was stirred at room temperature for 24 hours. The reaction solution was evaporated under reduced pressure to remove the solvent THF, and the residue was dissolved with a small amount of ethyl acetate. The solvent was eluted, and the eluent was evaporated under reduced pressure to remove the solvent, and DMEA ester of tamibarotene (white powder, yield 75.9%) was prepared. mp 138.0-139.0°C.

Embodiment 3

[0071] Embodiment 3: Tamibarotene N, the preparation of N-dimethylethanolamine (DMEA) ester hydrochloride

[0072] Dissolve the DMEA ester of tamibarotene (4.23g, 10mmol) in 100ml of ethyl acetate, add 100ml of anhydrous HCl saturated ethyl acetate solution under stirring at room temperature, stir at room temperature for 1 hour, evaporate the solvent under reduced pressure, and then Add 200 ml of ethyl acetate to dissolve the residue, and evaporate the solvent under reduced pressure to obtain tamibarotene DMEA ester hydrochloride (white powder, yield 95.6%). mp 215.0-217.0°C. 1 HNMR (DMSO-d 6 )δ: 1.240~1.252(m, 12H, 4×CH 3 ); 1.636(s, 4H, 2×CH 2 ); 2.882(s, 6H, 2×CH 3 ); 3.546 (s, 2H, N-CH 2 ); 4.629 ~ 4.645 (t, J = 4.8Hz, 2H, O-CH 2 ); 7.293~7.308(d, J=9.0Hz, 1H, ArH); 7.575~7.589(m, 1H, ArH); 7.694~7.697(d, J=1.8Hz, 1H, ArH); 8.093~8.107(d , J=8.4Hz, 2H, 2×ArH); 8.194~8.208 (d, J=8.4Hz, 2H, 2×ArH); 10.114 (s, 1H, NH); 10.320 (s, 1H, HCl).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a water-soluble prodrug of tamibarotene, and a preparation method and applications thereof and belongs to the technical fields of organic compound synthesis and medical applications. The water-soluble prodrug of tamibarotene has favorable water solubility and suitable drug crystal form, and therefore, is suitable to be used as a raw material for medical preparations and especially suitable for preparing injections. Particularly, the invention provides medical acceptable salts of tamibarotene DMEA ester, which have the general formula (I), wherein HA is HCl, H2SO4, HNO3,H3PO4, HOAc, paratoluenesulfonic acid, maleic acid, succinic acid, citric acid or L(+)-tartaric acid.

Description

technical field [0001] The invention relates to a water-soluble prodrug of tamibarotene, a preparation method and application thereof. It belongs to the technical field of organic compound synthesis and medical application. Background technique [0002] Tamibarotene (tamibarotene, 1), the chemical name is 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] Benzoic acid is a new type of selective retinoic acid receptor alpha agonist developed by Japan Nippon Shinyaku Company, which was first launched in Japan in June 2005 (Drugs Fut 30:688-693, 2005). The drug is mainly used clinically for the treatment of various types of relapsed or refractory acute promyelocytic leukemia (APL) (Gan To Kagaku Ryoho 33:397-401, 2006). Compared with other drugs, it has the advantages of high curative effect, not easy to produce drug resistance, and small adverse reactions. The chemical structural formula of Tamibarotene is as follows (1): [0003] [0004] Tamibarotene is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C235/84C07C231/12A61K31/235A61P35/00A61P35/02
Inventor 徐文方边海勇齐永秀
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com